LIXT

LIXTE BIOTECHNOLOGY HLDGS IN

LIXT·539319301·US·Common Stock·Healthcare - Biotechnology-13D/G

LIXT (LIXTE BIOTECHNOLOGY HLDGS IN) is held by 12 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($4.1M), SCOTIA CAPITAL INC. ($2.1M), GEODE CAPITAL MANAGEMENT, LLC ($1.1M). Net institutional sentiment: Mixed.

12
Holders
$9.5M
Total Value
67% (15)
Consensus
10 buying - 5 selling
13F: Insider & Congress: Updated regularly
LIXT

Smart Money Verdict

View all
Loading verdict
Held by 12 funds

Who's Trading

Source dates: Price Aug 14, 2026 · Insiders none · Activists Jun 9, 2026 · Congress none

ActivistSEStrategic EP, LLC5.1%Jun 9, 2026

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
555,476(+1022.6%)$4.1M0.0%-42.25%
43
Unchanged
283,162$2.1M0.0%+6.32%
0
Increased
143,036(+143.0%)$1.1M0.0%-30.13%
41
New
75,958$563,6090.0%-45.42%
37
Increased
75,096(+331.7%)$557,2120.0%-41.33%
27
Increased
67,280(+92.0%)$499,2180.0%-19.65%
38
Decreased
38,130(-40.9%)$282,9250.0%-12.00%
0
New
27,655$205,2000.0%-45.42%
35
New
13,771$102,1810.0%-45.42%
30
New
6,400$47,4880.0%-45.42%
31
New
246$1,8250.0%-45.42%
17
New
5$370.0%-45.42%
17
Exited
0(-100.0%)$173,6300.0%+138.46%
0
Exited
0(-100.0%)$71,9790.0%+111.92%
0
Exited
0(-100.0%)$34,0000.0%+160.35%
0
Exited
0(-100.0%)$285,5100.0%+55.30%
0
LIXTLIXTLIXTE BIOTECHNOLOGY HLDGS IN

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used